M.R. Boyd

1.1k total citations · 1 hit paper
8 papers, 1.0k citations indexed

About

M.R. Boyd is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, M.R. Boyd has authored 8 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Computational Theory and Mathematics. Recurrent topics in M.R. Boyd's work include Cancer therapeutics and mechanisms (2 papers), Computational Drug Discovery Methods (2 papers) and Lanthanide and Transition Metal Complexes (1 paper). M.R. Boyd is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Computational Drug Discovery Methods (2 papers) and Lanthanide and Transition Metal Complexes (1 paper). M.R. Boyd collaborates with scholars based in United States, Norway and India. M.R. Boyd's co-authors include Kenneth D. Paull, Richard Simon, Robert H. Shoemaker, Dominic A. Scudiero, Anne Monks, Larry Rubinstein, Philip Skehan, Adaline C. Smith, Susan Kenney and David T. Vistica and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

M.R. Boyd

8 papers receiving 972 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines

1990 859 citations Larry Rubinstein, Robert H. Shoemaker et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.R. Boyd United States	7	568	269	204	110	97	8	1.0k
Ruth I. Geran United States	9	624 1.1×	225 0.8×	318 1.6×	126 1.1×	129 1.3×	12	1.3k
Denyse Bagrel France	23	546 1.0×	433 1.6×	154 0.8×	161 1.5×	58 0.6×	48	1.2k
Rémy Kachadourian United States	18	618 1.1×	231 0.9×	368 1.8×	100 0.9×	88 0.9×	20	1.3k
Jian Ding China	19	746 1.3×	287 1.1×	211 1.0×	238 2.2×	140 1.4×	39	1.5k
Chong Ock Lee South Korea	21	773 1.4×	310 1.2×	303 1.5×	92 0.8×	75 0.8×	53	1.3k
Glenn A. Hofmann United States	17	934 1.6×	302 1.1×	299 1.5×	142 1.3×	48 0.5×	26	1.3k
Janique Dewelle Belgium	15	590 1.0×	288 1.1×	171 0.8×	82 0.7×	92 0.9×	18	1.1k
I.H. Hall United States	23	718 1.3×	472 1.8×	225 1.1×	68 0.6×	270 2.8×	82	1.5k
Hisashi Shinkai Japan	14	573 1.0×	291 1.1×	112 0.5×	217 2.0×	158 1.6×	27	1.6k
Robert D. Sindelar United States	14	466 0.8×	203 0.8×	93 0.5×	70 0.6×	39 0.4×	35	797

Countries citing papers authored by M.R. Boyd

Since Specialization

Citations

This map shows the geographic impact of M.R. Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.R. Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.R. Boyd more than expected).

Fields of papers citing papers by M.R. Boyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.R. Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.R. Boyd. The network helps show where M.R. Boyd may publish in the future.

Co-authorship network of co-authors of M.R. Boyd

This figure shows the co-authorship network connecting the top 25 collaborators of M.R. Boyd. A scholar is included among the top collaborators of M.R. Boyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.R. Boyd. M.R. Boyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Vistica, David T., Susan Kenney, Miriam L. Hursey, & M.R. Boyd. (1996). Role of membrane potential in the accumulation of quaternized ellipticines by human tumor cell lines.. Journal of Pharmacology and Experimental Therapeutics. 279(2). 1018–1025. 6 indexed citations

2.

Kenney, Susan, et al.. (1995). Uptake and cytotoxicity of 9-methoxy-N2-methylellipticinium acetate in human brain and non-brain tumor cell lines. Biochemical Pharmacology. 49(1). 23–32. 15 indexed citations

3.

Vistica, David T., Susan Kenney, Miriam L. Hursey, & M.R. Boyd. (1994). Cellular Uptake as a Determinant of Cytotoxicity of Quarternalized Ellipticines to Human Brain Tumor Cells. Biochemical and Biophysical Research Communications. 200(3). 1762–1768. 14 indexed citations

4.

Rubinstein, Larry, Robert H. Shoemaker, Kenneth D. Paull, et al.. (1990). Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines. JNCI Journal of the National Cancer Institute. 82(13). 1113–1117. 859 indexed citations breakdown →

5.

Paull, Kenneth D., et al.. (1988). Reproducibility and response patterns of the ic50 values and relative cell line sensitivities from the nci human tumor cell line drug screening project. 29. 488. 3 indexed citations

6.

Minchin, Rodney F., et al.. (1985). Metabolism of 2-acetylaminofluorene in isolated rabbit pulmonary cells. Evidence for the heterogeneous distribution of monooxygenase activity in lung tissue.. Drug Metabolism and Disposition. 13(4). 406–411. 10 indexed citations

7.

Smith, Adaline C. & M.R. Boyd. (1984). Preferential effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on pulmonary glutathione reductase and glutathione/glutathione disulfide ratios: possible implications for lung toxicity.. Journal of Pharmacology and Experimental Therapeutics. 229(3). 658–663. 65 indexed citations

8.

Wolf, C. Roland, Charles N. Statham, M G McMenamin, et al.. (1982). The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.. Molecular Pharmacology. 22(3). 738–744. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact